Quantum-Si
Quantum-Si's Q4 Revenues Grow Threefold
For the three months ended Dec. 31, 2024, the Guilford, Connecticut-based company posted $1.2 million in revenues, up from $400,000 in Q4 2023.
People in the News at Seer, Quantum-Si, Nautilus Biotechnology, Bio-Techne, FYR Diagnostics
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
GenomeWeb Top 40 Rises 10 Percent in January, Outpacing Gains in Broader Market
The Dow Jones Industrial Average rose 5 percent while the Nasdaq rose 2 percent, and the Nasdaq Biotech Index rose 5 percent.
Quantum-Si, Idex Health & Science Partner on Optics Development for Proteomics Platform
Idex, a developer of optics, fluidics, and microfluidics for the life sciences, will develop and manufacture the optical detection module for the Proteus system.
Quantum-Si Prices $50M Registered Direct Offering of Common Stock
The protein sequencing firm is selling 15,625,000 shares of common stock at $3.20 per share to certain institutional investors.
Dec 5, 2024
Nov 26, 2024
Nov 25, 2024
Quantum-Si Laying off 23 Percent of Workforce
Aug 22, 2024
Aug 7, 2024
Quantum-Si Q2 Revenues Rise More Than Threefold
May 9, 2024